XIAMEN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- STAR FASHION CULTURE HOLDINGS LIMITED (NASDAQ: STFS) (the “Company” or “STFS”) today announced that on October 6, 2025, STAR FASHION CULTURE HOLDINGS LIMITED (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from August 20, 2025 to October 3, 2025, the Company no longer meets the continued listing requirement of Nasdaq u ...

Core Insights - Plug Power Inc. has successfully completed the first phase of hydrogen supply delivery for the H2CAST project in Germany, demonstrating the scalability of its hydrogen production and trucking capabilities [1][2][3] - The project involves repurposing salt caverns for renewable hydrogen storage, which is essential for seasonal and high-capacity storage, contributing to the energy transition in Europe [1][5] - Plug Power's successful delivery of 44.5 metric tons of hydrogen and subsequent mandate for an additional 35 metric tons highlights the company's leadership in the hydrogen economy [2][3] Company Operations - Plug Power has established a fleet of 36 Multi Element Gas Containers (MEGCs) to enhance its hydrogen delivery capabilities, rated at 350/380 bar pressure standards [3] - The company is expanding its hydrogen production capacity in Europe, indicating strong market demand for its vertically-integrated approach [3][5] - Plug's engineering team has developed a dedicated unloading skid for the H2CAST facility, showcasing its ability to provide tailored solutions for seamless delivery [4] Market Position - The successful execution of projects like H2CAST positions Plug Power as a key player in the European hydrogen infrastructure, reinforcing its status as a global industrial gas company [5][6] - Plug Power has deployed over 72,000 fuel cell systems and 275 fueling stations globally, making it the largest user of liquid hydrogen [7] - The company is rapidly expanding its hydrogen generation network, with operational plants in Georgia, Tennessee, and Louisiana capable of producing 40 tons of hydrogen per day [7]

SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral presentation at ObesityWeek 2025 November 4-7 in Atlanta. In addition, Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer of iBio, will deliver an oral presentation at PEGS Europe 2025 November 11–13 in Lisbon. “We are excited to share add ...

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2025. Third quarter 2025 net revenue1 was $1.3 billion, an increase of 15% over the third quarter of 2024, or up 11% on an organic2 basis. This included Solutions3 revenue growing 15%, or up 10% on an organic basis.Annualized Recurring Revenue (ARR)4 of $3.0 billion increased 10% over the third quarter of 2024, or up 9% on an organic basis. Annualized SaaS revenue increased 12%, ...

VANCOUVER, British Columbia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce the completion of a 20-hole, 8,000-foot confirmation drill program at its JD-7 mine, one of the five mines (JD5, JD-6, JD-7, JD-8 and JD-9) which make up the Company’s Paradox Mine Complex. The drill results will be incorporated into a new uranium and vanadium resource report in Q1/26, alongside the additional drilling to be complete ...

MONTVALE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal third quarter ended September 30, 2025. For the quarter, the Company reported net sales of $267.6 million, net earnings of $40.3 million, adjusted EBITDA(a) of $71.4 million, and free cash flow(a) of $50.7 million. Ted Harris, Chairman, President and CEO of Balchem said, “In the third quarter, our company continued to deliver strong growth, fueled by the ongoing market pe ...

TUCSON, Ariz., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (NASDAQ: MCW), the nation’s premier car wash company, today announced the acquisition of five Whistle Express locations in Lubbock, Texas currently operated under the Take 5 Car Wash brand. The transaction expands Mister Car Wash’s footprint in the Lubbock market from four to nine convenient locations, establishing a leading market position across the city. Stephens Inc. served as exclusive financial advisor to Whistle Express on the div ...

TALLAHASSEE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $16.0 million, or $0.93 per diluted share, for the third quarter of 2025 compared to $15.0 million, or $0.88 per diluted share, for the second quarter of 2025, and $13.1 million, or $0.77 per diluted share, for the third quarter of 2024. QUARTER HIGHLIGHTS (3rd Quarter 2025 versus 2nd Quarter 2025) Income Statement Tax-equivalent net interest incom ...

HAMBURG, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”), (Nasdaq: XCH), a global leader in integrated EV charging solutions, today published its 2024 Environmental, Social and Governance Report (the “2024 ESG Report”). The Report highlights XCharge's achievements and transformative progress toward its commitment to innovate beyond charging by delivering smart and scalable solutions that optimize energy efficiency. Key highlights from the 2024 ESG Report: - ESG Achieveme ...

SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced initiation of th ...